123 related articles for article (PubMed ID: 34132166)
21. Association of polymorphisms of complement factor I rs141853578 (G119R) with age-related macular degeneration in Iranian population.
Bonyadi M; Norouzi N; Babaei E; Jabbarpoor Bonyadi MH; Javadzadeh A; Yaseri M; Soheilian M
Int Ophthalmol; 2019 Mar; 39(3):551-556. PubMed ID: 29392637
[TBL] [Abstract][Full Text] [Related]
22. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
[TBL] [Abstract][Full Text] [Related]
23. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population.
Medina FMC; Motta AALD; Takahashi WY; Carricondo PC; Motta MMDS; Melo MB; Vasconcellos JPC
Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277
[TBL] [Abstract][Full Text] [Related]
24. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.
Ambreen F; Ismail M; Qureshi IZ
Mol Vis; 2015; 21():985-99. PubMed ID: 26330749
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 1 beta promoter polymorphism is associated with keratoconus in a Japanese population.
Mikami T; Meguro A; Teshigawara T; Takeuchi M; Uemoto R; Kawagoe T; Nomura E; Asukata Y; Ishioka M; Iwasaki M; Fukagawa K; Konomi K; Shimazaki J; Nishida T; Mizuki N
Mol Vis; 2013; 19():845-51. PubMed ID: 23592922
[TBL] [Abstract][Full Text] [Related]
26. Association of complement factor H Y402H polymorphism and age-related macular degeneration in Brazilian patients.
Teixeira AG; Silva AS; Lin FL; Velletri R; Bavia L; Belfort R; Isaac L
Acta Ophthalmol; 2010 Aug; 88(5):e165-9. PubMed ID: 20626361
[TBL] [Abstract][Full Text] [Related]
27. Complement factor H 402H variant and reticular macular disease.
Smith RT; Merriam JE; Sohrab MA; Pumariega NM; Barile G; Blonska AM; Haans R; Madigan D; Allikmets R
Arch Ophthalmol; 2011 Aug; 129(8):1061-6. PubMed ID: 21825189
[TBL] [Abstract][Full Text] [Related]
28. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration.
Kaur I; Hussain A; Hussain N; Das T; Pathangay A; Mathai A; Hussain A; Nutheti R; Nirmalan PK; Chakrabarti S
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3729-35. PubMed ID: 16936080
[TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing of extreme age-related macular degeneration phenotypes.
Sardell RJ; Bailey JN; Courtenay MD; Whitehead P; Laux RA; Adams LD; Fortun JA; Brantley MA; Kovach JL; Schwartz SG; Agarwal A; Scott WK; Haines JL; Pericak-Vance MA
Mol Vis; 2016; 22():1062-76. PubMed ID: 27625572
[TBL] [Abstract][Full Text] [Related]
30. Influence of VEGF-C936T genetic variant on age-related macular degeneration.
Gonçalves FT; Cezario SM; Calastri MC; Oliveira CI; Souza DR; Pinhel MA; Cotrim CC; Jorge R; Siqueira RC
Arq Bras Oftalmol; 2015; 78(5):290-4. PubMed ID: 26466227
[TBL] [Abstract][Full Text] [Related]
31. CC chemokine receptor-3 as new target for age-related macular degeneration.
Sharma NK; Gupta A; Prabhakar S; Singh R; Bhatt AK; Anand A
Gene; 2013 Jul; 523(1):106-11. PubMed ID: 23566847
[TBL] [Abstract][Full Text] [Related]
32. Investigation of Interleukin-1β Polymorphisms in Prostate Cancer.
Yencilek F; Yildirim A; Yilmaz SG; Altinkilic EM; Dalan AB; Bastug Y; Isbir T
Anticancer Res; 2015 Nov; 35(11):6057-61. PubMed ID: 26504029
[TBL] [Abstract][Full Text] [Related]
33. Complement factor B polymorphism 32W protects against age-related macular degeneration.
Hughes AE; Mullan GM; Bradley DT
Mol Vis; 2011 Apr; 17():983-8. PubMed ID: 21541267
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
[TBL] [Abstract][Full Text] [Related]
35. Association Between Monocyte Chemotactic Protein 1 Variants and Age-Related Macular Degeneration Onset Among Chinese People.
Zhang Y; Zhao G
Med Sci Monit; 2020 Jun; 26():e921584. PubMed ID: 32485729
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
[TBL] [Abstract][Full Text] [Related]
37. Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.
Abbas RO; Azzazy HM
Ophthalmic Genet; 2013 Dec; 34(4):209-16. PubMed ID: 23362846
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration.
Goverdhan SV; Ennis S; Hannan SR; Madhusudhana KC; Cree AJ; Luff AJ; Lotery AJ
Br J Ophthalmol; 2008 Apr; 92(4):537-40. PubMed ID: 18310311
[TBL] [Abstract][Full Text] [Related]
39. Correlation between the interactions of ABCA4 polymorphisms and smoking with the susceptibility to age-related macular degeneration.
Wu Y; Tian L; Huang Y
Int J Clin Exp Pathol; 2015; 8(6):7403-8. PubMed ID: 26261643
[TBL] [Abstract][Full Text] [Related]
40. Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.
Habibi I; Sfar I; Kort F; Aounallah-Skhiri H; Chebil A; Chouchene I; Bouraoui R; Limaiem R; Largheche L; Jendoubi-Ayed S; Makhlouf M; Ben Abdallah T; Ayed K; El Matri L; Gorgi Y
Ophthalmic Res; 2013; 49(4):177-84. PubMed ID: 23306536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]